ReviewFrontiers in oncology2024

Bispecific antibodies for the treatment of relapsed/refractory multiple myeloma: updates and future perspectives.

Ricardo D Parrondo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.